NDC 71335-0950 – Buprenorphine

Buprenorphine Hydrochloride 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-0950

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA207276
Marketed since
October 25, 2017
Listing expires
December 31, 2026
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (8)

Package NDCDescriptionSince
71335-0950-160 TABLET in 1 BOTTLE (71335-0950-1)Sep 13, 2018
71335-0950-290 TABLET in 1 BOTTLE (71335-0950-2)Sep 13, 2018
71335-0950-330 TABLET in 1 BOTTLE (71335-0950-3)Sep 23, 2022
71335-0950-47 TABLET in 1 BOTTLE (71335-0950-4)Sep 23, 2022
71335-0950-528 TABLET in 1 BOTTLE (71335-0950-5)Sep 23, 2022
71335-0950-61 TABLET in 1 BOTTLE (71335-0950-6)Sep 23, 2022
71335-0950-712 TABLET in 1 BOTTLE (71335-0950-7)Sep 23, 2022
71335-0950-8120 TABLET in 1 BOTTLE (71335-0950-8)Sep 23, 2022

Other Buprenorphine products